系统性硬化症肾危象的分类再思考及其病理生理学
本文综述提出,将系统性硬化症肾危象(SRC)简单分为高血压型或血压正常型可能忽略其独特病理生理学,患者常混合狭义SRC(nd-SRC)与系统性硬化症相关血栓性微血管病(SSc-TMA)特征。基于临床经验与文献复习,区分nd-SRC与SSc-TMA有助治疗与预后判断,因SSc-TMA与既往激素使用及不良预后关联更强。
要点
- SRC的血压分型可能掩盖nd-SRC与SSc-TMA混合病理特征。
- SSc-TMA与既往激素使用及不良预后的关联强于nd-SRC。
- nd-SRC先血压显著升高和肾功能恶化后轻度血小板减少;SSc-TMA先严重血小板减少后血压升高和肾功能恶化。
核心结论
- 更好区分同时具有nd-SRC和TMA临床特征的患者可改善治疗策略。
研究设计与样本
- 综述,基于临床经验与文献复习。
主要发现
- SSc-TMA与既往激素使用及不良预后的关联强于nd-SRC。
- nd-SRC典型表现为初期血压显著升高和肾功能恶化,随后轻度血小板减少。
- SSc-TMA典型表现为首先严重血小板减少,随后血压升高和肾功能恶化。
临床怎么用
- 不应仅凭血压区分nd-SRC与SSc-TMA,详细临床病程更有帮助。
- 应考虑各病理条件的受累程度以决定治疗干预和预后预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Categorization of scleroderma renal crisis (SRC) as hypertensive or normotensive can potentially overlook the underlying pathophysiology that might be unique in each patient, as they often exhibit a mixture of distinct pathological characteristics of narrowly defined SRC (nd-SRC) and systemic sclerosis associated thrombocytic micro-angiopathy (SSc-TMA). In this review, we provide evidence suggesting that better categorization of patients presenting with certain clinical features of both nd-SRC and TMA will improve treatment approaches. Based on our clinical experience and literature review, distinguishing between nd-SRC and SSc-TMA is important because the association of SSc-TMA with prior steroid administration and poor prognosis was stronger than that of nd-SRC. Although the two pathological entities cannot be easily distinguished based on blood pressure, we suggest that the detailed clinical course is helpful. Typically, nd-SRC exhibits prominently elevated blood pressure and worsening of renal function initially, followed by mild thrombocytopenia. Conversely, SSc-TMA presents first with severe thrombocytopenia, followed by elevated blood pressure and renal function deterioration. The degree of involvement in each pathological condition should be considered for determination of appropriate therapeutic interventions and prognostic prediction.
引用
- Yamashita H, Kamei R, Kaneko H, et al. Classifications of scleroderma renal crisis and reconsideration of its pathophysiology. Rheumatology (Oxford). 2019. PMID: 31566243. doi:10.1093/rheumatology/kez435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。